JP2005513103A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513103A5
JP2005513103A5 JP2003554193A JP2003554193A JP2005513103A5 JP 2005513103 A5 JP2005513103 A5 JP 2005513103A5 JP 2003554193 A JP2003554193 A JP 2003554193A JP 2003554193 A JP2003554193 A JP 2003554193A JP 2005513103 A5 JP2005513103 A5 JP 2005513103A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
compound
agent
ophthalmically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003554193A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513103A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/039316 external-priority patent/WO2003053436A1/en
Publication of JP2005513103A publication Critical patent/JP2005513103A/ja
Publication of JP2005513103A5 publication Critical patent/JP2005513103A5/ja
Pending legal-status Critical Current

Links

JP2003554193A 2001-12-20 2002-12-09 緑内障の処置のための新規ベンゾジフランイミダゾリンおよびベンゾフランイミダゾリン誘導体ならびにそれらの使用 Pending JP2005513103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34337801P 2001-12-20 2001-12-20
PCT/US2002/039316 WO2003053436A1 (en) 2001-12-20 2002-12-09 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma

Publications (2)

Publication Number Publication Date
JP2005513103A JP2005513103A (ja) 2005-05-12
JP2005513103A5 true JP2005513103A5 (https=) 2006-01-12

Family

ID=23345873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554193A Pending JP2005513103A (ja) 2001-12-20 2002-12-09 緑内障の処置のための新規ベンゾジフランイミダゾリンおよびベンゾフランイミダゾリン誘導体ならびにそれらの使用

Country Status (13)

Country Link
US (1) US7208512B2 (https=)
EP (1) EP1455780A4 (https=)
JP (1) JP2005513103A (https=)
KR (1) KR20040068315A (https=)
CN (1) CN1268334C (https=)
AR (1) AR037880A1 (https=)
AU (1) AU2002353088B2 (https=)
BR (1) BR0215172A (https=)
CA (1) CA2469904A1 (https=)
MX (1) MXPA04006029A (https=)
TW (1) TW593302B (https=)
WO (1) WO2003053436A1 (https=)
ZA (1) ZA200404473B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
TW200520760A (en) 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES323985A1 (es) 1966-02-26 1966-12-16 Blade Pique Juan Procedimiento para la obtenciën de derivados del imidazol
US5011846A (en) 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0445073A1 (de) 1990-02-27 1991-09-04 Ciba-Geigy Ag Benzofurane
EP0536223B1 (en) 1990-06-26 2004-09-15 AorTech Biomaterials Pty Ltd Polyurethane or polyurethane-urea elastomeric compositions
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
EP0593513B1 (en) 1991-06-21 1998-10-28 Smithkline Beecham Plc Tryptamine analogues, their synthesis and their use as 5-ht1-like receptors or 5-ht2 receptor agonistes
GB9216380D0 (en) 1992-07-31 1992-09-16 Glaxo Group Ltd Medicaments
US5290781A (en) 1993-01-05 1994-03-01 Iolab Corporation Ketaneserinol as an agent to reduce intraocular pressure
US5891131A (en) 1993-02-01 1999-04-06 Arizona Board Of Regents Method and apparatus for automated simulation and design of corneal refractive procedures
TW334423B (en) 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
TW270114B (https=) 1993-10-22 1996-02-11 Hoffmann La Roche
US5538974A (en) 1994-01-27 1996-07-23 Senju Pharamceutical Co., Ltd. Ophthalmic composition for lowering intraocular pressure
ATE166227T1 (de) 1994-03-18 1998-06-15 Senju Pharma Co Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes
US5874477A (en) 1994-08-12 1999-02-23 The University Of Hawaii Method of treatment for malaria utilizing serotonin receptor ligands
TW403738B (en) 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives
US5998467A (en) 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy
AU2340997A (en) 1996-03-27 1997-10-17 Merck & Co., Inc. A method for inhibiting clot formation
US5902815A (en) 1996-09-03 1999-05-11 Washington University Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
WO1998018458A1 (en) 1996-10-31 1998-05-07 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
GB9700899D0 (en) 1997-01-17 1997-03-05 Smithkline Beecham Plc Novel treatment
MXPA00010060A (es) 1998-04-14 2004-04-23 Arena Pharm Inc Receptores de serotonina humana constitutivamente activados, no endogenos y moduladores de molecula pequenos de los mismos.
CN1301161A (zh) 1998-05-19 2001-06-27 艾尔科实验室公司 用于治疗眼睛和中枢神经系统障碍的血清素激活的5ht7受体化合物
GB9819033D0 (en) 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
GB9819035D0 (en) 1998-09-01 1998-10-28 Cerebrus Res Ltd Chemical compounds VII
CN1269484C (zh) 1998-09-18 2006-08-16 艾尔科实验室公司 用于治疗青光眼的5-羟色胺激活性激动剂
CA2351385A1 (en) 1998-12-17 2000-06-22 American Home Products Corporation 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)quinoxalin-5(6h)one derivates being 5ht2c agonists
GB9902047D0 (en) 1999-01-29 1999-03-17 Cerebrus Ltd Chemical compounds XI
WO2001040183A1 (en) 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma
BR0109193A (pt) 2000-03-17 2003-05-27 Alcon Inc Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma
AU2001219185A1 (en) 2000-03-17 2001-10-03 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
US6806285B1 (en) 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
WO2001070745A1 (en) 2000-03-17 2001-09-27 Alcon, Inc. Pyranoindoles for treating glaucoma
BR0017157A (pt) 2000-03-17 2002-11-26 Alcon Inc Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
BR0017158A (pt) 2000-03-17 2003-06-03 Alcon Inc Agonistas de 5ht2 para controlar a iop e tratar o glaucoma
WO2001070701A1 (en) 2000-03-17 2001-09-27 Alcon, Inc. 5-hydroxy indazole derivatives for treating glaucoma
JP2004532887A (ja) 2001-06-01 2004-10-28 アルコン,インコーポレイテッド 新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
JP2004534781A (ja) 2001-06-01 2004-11-18 アルコン,インコーポレイテッド 新規なアリールアミノプロパン類似体および緑内障治療へのこれらの使用
CA2447480A1 (en) 2001-06-01 2002-12-12 Alcon, Inc. Pyranoindazoles and their use for the treatment of glaucoma
US6884816B2 (en) 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
WO2003051291A2 (en) 2001-12-14 2003-06-26 Alcon, Inc. Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
WO2003051352A1 (en) 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
JP2006501245A (ja) 2002-08-30 2006-01-12 アルコン,インコーポレイテッド 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用
CA2492468A1 (en) 2002-09-24 2004-04-08 Virginia Commonwealth University .beta.-hydroxyphenylalkylamines and their use for treating glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
WO2004058725A1 (en) 2002-12-23 2004-07-15 Alcon, Inc. 1-alkyl-3-aminoindazoles

Similar Documents

Publication Publication Date Title
JP4934653B2 (ja) Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
JP2004532209A5 (https=)
JP4972551B2 (ja) 緑内障の予防又は治療剤
JP6449205B2 (ja) ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2001526218A5 (https=)
JP2004504348A5 (https=)
JP2003531118A5 (https=)
JP2004509857A5 (https=)
JP2009521494A5 (https=)
RU2008130111A (ru) (индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
RU2005132930A (ru) Аналоги простагландина в качестве антагонистов ep4 рецепторов
JP2005500363A5 (https=)
BR0308738A (https=)
JP2005513103A5 (https=)
EP1078923A3 (en) Process for the preparation of benzothiophene derivatives
JP2018030878A (ja) 緑内障予防又は治療のための薬物療法
US20220387372A1 (en) Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor
JP2003528085A5 (https=)
WO2004017977A3 (en) 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
CA2488001A1 (en) 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
EP1621198A3 (en) Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
JP2005511764A5 (https=)
JP2010514733A5 (https=)
JP2003535821A5 (https=)
WO2004071428A3 (en) 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure